Table 3.
Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of flatulence and declaring presence of flatulence (comparison conducted using U Mann-Whitney test)
|
Individuals declaring lack of flatulence (n = 46) |
Individuals declaring flatulence (n = 10) |
P value | |||
| Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | ||
| Intake | |||||
| Daidzein (μg) | 147.4 ± 165.6 | 115.01 (3.3-977.7) | 131.4 ± 843 | 109.8 (19.0-278.0) | 0.7727 |
| Genistein (μg) | 187.6 ± 225.4 | 140.01 (2.3-1428.3) | 131.1 ± 177.6 | 78.31 (7.3-586.7) | 0.2186 |
| Glycitein (μg) | 2.2 ± 9.7 | 0.01 (0.0-56.0) | 0.4 ± 1.3 | 0.01 (0.0-4.0) | 0.7738 |
| Total isoflavones (μg) | 337.2 ± 293.4 | 302.51 (18.0-1574.0) | 262.9 ± 232.2 | 220.81 (37.3-833.0) | 0.4162 |
| Intake per 1000 kcal | |||||
| Daidzein (μg/1000 kcal) | 78.9 ± 89.1 | 53.91 (1.3-392.7) | 74.3 ± 56.6 | 60.8 (12.1-56.6) | 0.6455 |
| Genistein (μg/1000 kcal) | 97.3 ± 121.5 | 68.11 (1.4-759.2) | 79.4 ± 128.7 | 32.31 (3.6-426.6) | 0.2268 |
| Glycitein (μg/1000 kcal) | 1.4 ± 6.1 | 0.01 (0.0-37.4) | 0.3 ± 0.9 | 0.01 (0.0-2.9) | 0.7738 |
| Total isoflavones (μg /1000 kcal) | 177.6 ± 162.9 | 133.51 (8.3-836.7) | 154.0 ± 170.0 | 133.91 (21.7-605.7) | 0.5854 |
1
Nonparametric distribution (verified using the Shapiro-Wilk test; P < 0.05).